Literature DB >> 27196444

Karyomegalic Interstitial Nephritis: A Case Report and Review of the Literature.

Pierre Isnard1, Marion Rabant, Jacques Labaye, Corinne Antignac, Bertrand Knebelmann, Mohamad Zaidan.   

Abstract

Karyomegalic interstitial nephritis is a rare cause of hereditary chronic interstitial nephritis, described for the first time over 40 years ago.A 36-year-old woman, of Turkish origin, presented with chronic kidney disease and high blood pressure. She had a history of recurrent upper respiratory tract infections but no familial history of nephropathy. Physical examination was unremarkable. Laboratory tests showed serum creatinine at 2.3 mg/dL with an estimated glomerular filtration rate of 26 mL/min/1.73m, and gamma-glutamyl transpeptidase and alkaline phosphatase at 3 and 1.5 times the upper normal limit. Urinalysis showed 0.8 g/day of nonselective proteinuria, microscopic hematuria, and aseptic leukocyturia. Immunological tests and tests for human immunodeficiency and hepatitis B and C viruses were negative. Complement level and serum proteins electrophoresis were normal. Analysis of the renal biopsy showed severe interstitial fibrosis and tubular atrophy. Numerous tubular cells had nuclear enlargement with irregular outlines, hyperchromatic aspect, and prominent nucleoli. These findings were highly suggestive of karyomegalic interstitial nephritis, which was further confirmed by exome sequencing of FAN1 gene showing an identified homozygous frameshift mutation due to a one-base-pair deletion in exon 12 (c.2616delA).The present case illustrates a rare but severe cause of hereditary interstitial nephritis, sometimes accompanied by subtle extrarenal manifestations. Identification of mutations in FAN1 gene underscores recent insights linking inadequate DNA repair and susceptibility to chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27196444      PMCID: PMC4902386          DOI: 10.1097/MD.0000000000003349

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


INTRODUCTION

Karyomegalic interstitial nephritis (KIN) is an uncommon hereditary cause of chronic interstitial nephritis described for the first time over 40 years ago.[1-3] In 1974, Burry et al[1] reported a young woman dying from hepatocellular carcinoma and who displayed dysplastic nuclei in the renal epithelium. The term of “KIN” was introduced by Mihatsch et al[3] in 1979 who described 3 cases of systemic karyomegaly associated with chronic interstitial nephritis. The disease presents as a slowly progressive chronic kidney disease, eventually leading to end-stage renal disease before the age of 50 years. Extrarenal features are absent or mild, consisting of recurrent upper respiratory tract infections and abnormal liver function tests. The presence of karyomegalic tubular epithelial cells on the renal biopsy specimen is the disease hallmark that makes it distinguishable from other common causes of chronic tubulointerstitial nephritis. More recently, the disease has been linked to mutations in the FAN1 (FANCD2/FANCI-Associated Nuclease 1) gene, a gene involved in the DNA damage response pathway, particularly in the kidney, shedding new lights on the potential link between defective DNA repair and chronic kidney disease progression.

CASE REPORT

A 36-year-old woman, of Turkish origin, was referred to our nephrology department because of impaired renal function. The patient was born in France and had a history of recurrent upper respiratory tract infections. She had no familial history of nephropathy, and reported no exposure to nephrotoxic medications, heavy metals, environmental or agricultural toxins, and no consumption of Chinese herbal medicine. Physical examination was unremarkable except for high blood pressure (164/94 mmHg). Serum creatinine was at 2.3 mg/dL with an estimated glomerular filtration rate of 26 mL/min/1.73m2. Serum electrolytes, calcium, and albumin levels were normal. Hemoglobin level was 10 g/dL (normal range [12-15]). The platelet and leukocyte counts were normal. Liver function tests revealed mild cholestasis with gamma-glutamyl transpeptidase and alkaline phosphatase at 3 and 1.5 times the upper normal limit. Urinalysis showed proteinuria (0.8 g/day), hematuria (15 red blood cells/mm3), and aseptic leukocyturia. No glucosuria was detected on repeated urinary dipsticks. Immunological tests were negative, including antinuclear, antineutrophilic cytoplasmic, antismooth muscle, antiliver/kidney microsomal, and antimitochondrial antibodies. Complement level and serum proteins electrophoresis were normal. Tests for human immunodeficiency and hepatitis B and C viruses were negative. Chest CT scan showed evidence of mild bronchiectasis and interstitial infiltrates of lung bases, consistent with the past history of recurrent respiratory tract infections (Figure 1A). Abdominal ultrasonography revealed no hepatic abnormality but showed small kidneys with an atrophic right kidney measured at 7 cm against 9.5 cm for the left one.
FIGURE 1

(A) Chest CT-scan showing bilateral bronchectasis with bronchial wall thickening (blue arrowheads). (B) Light microscopy at low magnification using Masson's trichrome staining showed chronic tubulointerstitial nephritis (green asters) with severe fibrosis, tubular atrophy, and inflammatory interstitial infiltrates. Globally sclerotic glomeruli (yellow asters) and severe vascular lesions (red asters) were also observed (original magnification x50). (C) Remarkably, numerous tubular cells in both the cortex and medulla showed nuclear enlargement with irregular outlines (orange arrows, original magnification x200). (D) Periodic acid-Schiff staining showing typical karyomegalic tubular epithelial cells (orange arrows) characterized by markedly enlarged nuclei with irregular outlines, and hyperchromatic and prominent nucleoli (original magnification x600).

(A) Chest CT-scan showing bilateral bronchectasis with bronchial wall thickening (blue arrowheads). (B) Light microscopy at low magnification using Masson's trichrome staining showed chronic tubulointerstitial nephritis (green asters) with severe fibrosis, tubular atrophy, and inflammatory interstitial infiltrates. Globally sclerotic glomeruli (yellow asters) and severe vascular lesions (red asters) were also observed (original magnification x50). (C) Remarkably, numerous tubular cells in both the cortex and medulla showed nuclear enlargement with irregular outlines (orange arrows, original magnification x200). (D) Periodic acid-Schiff staining showing typical karyomegalic tubular epithelial cells (orange arrows) characterized by markedly enlarged nuclei with irregular outlines, and hyperchromatic and prominent nucleoli (original magnification x600). A transjugular biopsy of the right kidney was performed. Analysis of the renal biopsy revealed 60% of sclerotic glomeruli, the remainder appearing normal with no deposits by immunofluorescence study. Predominant lesions included patchy but severe interstitial fibrosis, tubular atrophy, and arteriosclerosis (Figure 1B). Remarkably, numerous tubular cells in the cortex and medulla showed nuclear enlargement with irregular outlines, hyperchromatic aspect, and prominent nucleoli (Figure 1C, D). No intranuclear inclusions or virus-like particles were observed. Altogether, these findings were highly suggestive of karyomegalic interstitial nephritis (KIN), a hereditary cause of chronic interstitial nephritis. Consistently, genetic analysis by exome sequencing identified a homozygous frameshift mutation due to a one-base-pair deletion in exon 12 of FAN1 gene (c.2616delA), resulting in the appearance of a premature STOP codon. After 2 years of follow-up, the patient had experienced 3 episodes of lung infection, including 1 requiring hospitalization. Serum creatinine level was 2.7 mg/dL with an estimated glomerular filtration rate of 21 mL/min/1.73m2. Urinalysis showed an increase in proteinuria level up to 1.2 g/day and liver function tests still revealed mild cholestasis.

DISCUSSION

Chronic interstitial nephritis is a heterogeneous condition that may be secondary to a broad spectrum of causes, including drugs and toxins, infections, and immunological conditions, and other hereditary disorders. Frequently, no etiology can be identified, leading to the diagnosis of the so-called “idiopathic” forms. The clinical and biological setting of interstitial nephritis, including mild to moderate renal dysfunction, absence or mild degree of proteinuria, and/or urinary sediment abnormalities, often make physicians reluctant to perform a renal biopsy. Even if done, renal lesions are most often nonspecific, and definite etiological diagnosis may remain difficult to establish. KIN is an uncommon hereditary cause of chronic interstitial nephritis described for the first time over 40 years ago.[1-3] In 1974, Burry et al[1] reported the case of a young woman dying from hepatocellular carcinoma and who displayed dysplastic nuclei in the renal epithelium. The term of “KIN” was then introduced by Mihatsch et al[3] in 1979 who described 3 cases of systemic karyomegaly associated with chronic interstitial nephritis. Since then, <50 cases of KIN have been reported in the English literature (Table 1 ).[1-22] KIN usually presents as a slowly progressive chronic kidney disease, eventually leading to end-stage renal disease in the early adulthood.[8] Patients display mild proteinuria, usually of <1 g/day. More than 75% also have glucosuria, whereas less than one-third present with urinary sediment abnormalities, mostly consisting of hematuria.[11] Analysis of the renal biopsy specimen usually shows nonspecific but severe chronic interstitial fibrosis and tubular changes, associated with nonspecific glomerulosclerosis and vascular lesions. The presence of karyomegalic tubular epithelial cells, lining the proximal and distal tubules, and characterized by markedly enlarged and hyperchromatic nuclei, represent the disease hallmark.[8]
TABLE 1

Reported Cases of Karyomegalic Interstitial Nephritis in the English Literature

Reported Cases of Karyomegalic Interstitial Nephritis in the English Literature Reported Cases of Karyomegalic Interstitial Nephritis in the English Literature Almost half of patients display a past medical history of recurrent upper respiratory tract infections and abnormal liver function tests.[8,11] Consistently, karyomegaly has been described in the liver and lung, but also in other organs, including the brain, skin, and digestive tissues.[3,11] Nevertheless, and in sharp contrast to the kidney, extrarenal karyomegaly is usually associated with only subtle clinical and biological changes. Only 1 case of systemic karyomegaly with primary pulmonary manifestations and without significant kidney impairment has been reported in the literature.[19] Karyomegalic cells can also be detected in the urine samples.[11] Renal karyomegaly may be related to a few alternative causes, including viral infections, immunosuppressive therapy such as alkylating agents, and exposure to heavy metals and mycotoxins, particularly ochratoxin A.[9,23] In the present case, no exposure to the above-mentioned agents and no evidence for viral infections were identified. Historically, KIN was thought to be a hereditary disorder because almost half of patients had a familial history of nephropathy. Consistently, the disease has been recently ascribed to autosomal recessive mutations in the FAN1 gene, which encodes Fanconi anemia-associated nuclease 1.[17] This nuclease belongs to the Fanconi anemia DNA damage response pathway and is required for the repair of DNA interstrand crosslinks (Figure 2). The recognition of DNA interstrand crosslink by Fanconi Anemia Complementation group M (FANCM) and associated proteins leads to the recruitment of the Fanconi anemia core complex and monoubiquitylation of Fanconi Anemia Complementation group D2 (FANCD2) and Fanconi Anemia Complementation group I (FANCI). FAN1 is then recruited at sites of DNA damage by monoubiquitinated FANCD2 and cleaves DNA successively, allowing to excise an interstrand crosslink from 1 strand through flanking incisions. FAN1 is more specifically involved in the repair of interstrand crosslinks-induced DNA breaks by being required for efficient homologous recombination, and probably acts in the resolution of homologous recombination intermediates.[24] Patients with Fanconi anemia usually display developmental abnormalities, bone marrow failure, and predisposition to cancers.[25] Strikingly, contrary to other FAN genes, FAN1 mutations have not been associated with a Fanconi anemia phenotype, likely because of a predominant expression of the gene in the kidney, liver, and neuronal tissue.[17] Recently, Segui et al[26] linked colorectal cancer predisposition to monoallelic germline mutations in the FAN1 gene. Interestingly, in case of biallelic loss of FAN1, as observed in patients with KIN, development of cancer at early ages has also been reported in 2 cases.[1,3] Of note, contrary to KIN-associated biallelic mutations in FAN1, which localize toward the C-terminus of the protein, monoallelic mutations associated with hereditary colorectal cancer do not show a preferential gene location.[26] Interstrand crosslink lesions could be actually processed differentially depending on the organ affected, eventually leading to different clinical phenotypes.[17] In particular, FAN1 could be more specifically engaged in the repair of a possible “renal-specific” DNA damage. Godin et al[6] reported 2 related cases of KIN associated with a homozygous FAN1 mutation who also displayed detectable ochratoxin A in the urine and blood samples. Exposure to ochratoxin A has also been identified in a few other patients with KIN, suggesting that FAN1 mutations could render tubular cells more susceptible to environmental genotoxin-induced renal DNA damage (Figure 2). In this line, Chaki et al[27] also identified mutations in 2 other genes of the DNA damage response pathway in patients with renal ciliopathies, reinforcing the concept of a potential link between defective DNA damage repair and the pathogenesis of chronic kidney diseases.
FIGURE 2

Recent insights in the pathophysiology of karyomegalic interstitial nephritis. Tubular epithelial cells are exposed to various types of aggressions, potentially leading to cellular injury. In case of DNA damage with ICL, which may be favored by environmental genotoxins, FANCM is recruited at the site of ICL and initiates the recruitment of the Fanconi anemia core complex leading to the monoubiquitylation of FANCD2 and FANCI, and cell cycle blockade to allow DNA repair. FAN1 is then recruited by monoubiquitinated FANCD2 and cleaves DNA successively, allowing to excise an interstrand crosslink from 1 strand through flanking incisions. FAN1 has been reported to be more specifically involved in the repair of ICL-induced DNA breaks by being required for efficient homologous recombination, and probably acts in the resolution of homologous recombination intermediates. In the absence of FAN1, DNA repair is impaired resulting in the accumulation of DNA damage and impairment of cell proliferation. In particular, FAN1 could be more specifically engaged in the repair of a possible “renal-specific” DNA damage. FAN1 = FANCD2/FANCI-Associated Nuclease 1; FANCI = Fanconi Anemia Complementation group I, FANCD2 = Fanconi Anemia Complementation group D2, FANCM = Fanconi Anemia Complementation group M, ICL = interstrand crosslinks.

Recent insights in the pathophysiology of karyomegalic interstitial nephritis. Tubular epithelial cells are exposed to various types of aggressions, potentially leading to cellular injury. In case of DNA damage with ICL, which may be favored by environmental genotoxins, FANCM is recruited at the site of ICL and initiates the recruitment of the Fanconi anemia core complex leading to the monoubiquitylation of FANCD2 and FANCI, and cell cycle blockade to allow DNA repair. FAN1 is then recruited by monoubiquitinated FANCD2 and cleaves DNA successively, allowing to excise an interstrand crosslink from 1 strand through flanking incisions. FAN1 has been reported to be more specifically involved in the repair of ICL-induced DNA breaks by being required for efficient homologous recombination, and probably acts in the resolution of homologous recombination intermediates. In the absence of FAN1, DNA repair is impaired resulting in the accumulation of DNA damage and impairment of cell proliferation. In particular, FAN1 could be more specifically engaged in the repair of a possible “renal-specific” DNA damage. FAN1 = FANCD2/FANCI-Associated Nuclease 1; FANCI = Fanconi Anemia Complementation group I, FANCD2 = Fanconi Anemia Complementation group D2, FANCM = Fanconi Anemia Complementation group M, ICL = interstrand crosslinks. In summary, KIN is a rare but severe cause of chronic interstitial nephritis, sometimes accompanied by subtle extrarenal manifestations. Identification of mutations in FAN1 gene underscores recent insights linking inadequate DNA repair and susceptibility to chronic kidney disease.
TABLE 1 (Continued)

Reported Cases of Karyomegalic Interstitial Nephritis in the English Literature

  25 in total

Review 1.  Karyomegalic interstitial nephritis: report of 3 new cases and review of the literature.

Authors:  G Monga; G Banfi; M Salvadore; O Amatruda; C Bozzola; G Mazzucco
Journal:  Clin Nephrol       Date:  2006-05       Impact factor: 0.975

2.  A case of systemic karyomegaly associated with interstitial nephritis.

Authors:  M Vadiaka; F Sotsiou; C Koufos
Journal:  Ann Med Interne (Paris)       Date:  1998-09

3.  Karyomegalic nephropathy: an uncommon cause of progressive renal failure.

Authors:  Sunil Bhandari; Steven Kalowski; Paul Collett; Bridget E Cooke; Peter Kerr; Ronald Newland; John Dowling; John Horvath
Journal:  Nephrol Dial Transplant       Date:  2002-11       Impact factor: 5.992

4.  [Karyomegalic interstitial nephritis: A new French case].

Authors:  Jérôme Verine; Richard Reade; Anne Janin; Dominique Droz
Journal:  Ann Pathol       Date:  2010-04-14       Impact factor: 0.407

5.  Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling.

Authors:  Moumita Chaki; Rannar Airik; Amiya K Ghosh; Rachel H Giles; Rui Chen; Gisela G Slaats; Hui Wang; Toby W Hurd; Weibin Zhou; Andrew Cluckey; Heon Yung Gee; Gokul Ramaswami; Chen-Jei Hong; Bruce A Hamilton; Igor Cervenka; Ranjani Sri Ganji; Vitezslav Bryja; Heleen H Arts; Jeroen van Reeuwijk; Machteld M Oud; Stef J F Letteboer; Ronald Roepman; Hervé Husson; Oxana Ibraghimov-Beskrovnaya; Takayuki Yasunaga; Gerd Walz; Lorraine Eley; John A Sayer; Bernhard Schermer; Max C Liebau; Thomas Benzing; Stephanie Le Corre; Iain Drummond; Sabine Janssen; Susan J Allen; Sivakumar Natarajan; John F O'Toole; Massimo Attanasio; Sophie Saunier; Corinne Antignac; Robert K Koenekoop; Huanan Ren; Irma Lopez; Ahmet Nayir; Corinne Stoetzel; Helene Dollfus; Rustin Massoudi; Joseph G Gleeson; Sharon P Andreoli; Dan G Doherty; Anna Lindstrad; Christelle Golzio; Nicholas Katsanis; Lars Pape; Emad B Abboud; Ali A Al-Rajhi; Richard A Lewis; Heymut Omran; Eva Y-H P Lee; Shaohui Wang; Joann M Sekiguchi; Rudel Saunders; Colin A Johnson; Elizabeth Garner; Katja Vanselow; Jens S Andersen; Joseph Shlomai; Gudrun Nurnberg; Peter Nurnberg; Shawn Levy; Agata Smogorzewska; Edgar A Otto; Friedhelm Hildebrandt
Journal:  Cell       Date:  2012-08-03       Impact factor: 41.582

6.  Karyomegalic interstitial nephritis.

Authors:  M Godin; A Francois; F Le Roy; J P Morin; E Creppy; J Hemet; J P Fillastre
Journal:  Am J Kidney Dis       Date:  1996-01       Impact factor: 8.860

7.  Karyomegalic interstitial nephritis: a pitfall in urine cytology.

Authors:  David Palmer; Sharda Lallu; Philip Matheson; Peter Bethwaite; Keneth Tompson
Journal:  Diagn Cytopathol       Date:  2007-03       Impact factor: 1.582

8.  [Systemic karyomegaly with chronic interstitial nephritis. Discussion of the disease picture based on an autopsy case].

Authors:  H Moch; M Spöndlin; A Schmassmann; M J Mihatsch
Journal:  Pathologe       Date:  1994-02       Impact factor: 1.011

9.  Karyomegalic interstitial nephritis with focal segmental glomerulosclerosis: A rare association.

Authors:  S Radha; A Tameem; B S Rao
Journal:  Indian J Nephrol       Date:  2014-03

10.  Karyomegalic-like nephropathy, Ewing's sarcoma and ifosfamide therapy.

Authors:  Tom McCulloch; Andrew Prayle; Andy Lunn; Alan R Watson
Journal:  Pediatr Nephrol       Date:  2011-03-18       Impact factor: 3.714

View more
  8 in total

Review 1.  Genomic medicine for kidney disease.

Authors:  Emily E Groopman; Hila Milo Rasouly; Ali G Gharavi
Journal:  Nat Rev Nephrol       Date:  2018-01-08       Impact factor: 28.314

2.  Novel Homozygous FAN1 Mutation in a Familial Case of Karyomegalic Interstitial Nephritis.

Authors:  Priyanka J Koshy; Digumarthi V S Sudhakar; Sneha H Anupama; Milly Mathew; Rajeevalochana Parthasarthy; Kumarasamy Thangaraj; Muhammad Magdi Yaqoob; Georgi Abraham
Journal:  Indian J Nephrol       Date:  2020-02-19

Review 3.  FAN1, a DNA Repair Nuclease, as a Modifier of Repeat Expansion Disorders.

Authors:  Amit L Deshmukh; Antonio Porro; Mohiuddin Mohiuddin; Stella Lanni; Gagan B Panigrahi; Marie-Christine Caron; Jean-Yves Masson; Alessandro A Sartori; Christopher E Pearson
Journal:  J Huntingtons Dis       Date:  2021

4.  Association of karyomegalic interstitial nephritis with focal segmental glomerulosclerosis.

Authors:  Momal Tara Chand; Awais Zaka; Hong Qu
Journal:  Autops Case Rep       Date:  2021-11-12

5.  Exacerbated Renal and Hematologic Toxicities to Ifosfamide and Doxorubicin-Based Chemotherapy in a Patient with Retroperitoneal Liposarcoma Harboring a Germline Mutation in the WRN Gene.

Authors:  Beatriz Mendes Awni; Carlos Diego Holanda Lopes; Guilherme Harada; Alessandra Corte Real Salgues; Gilmar de Andrade França; Leonardo de Abreu Testagrossa; Marcelo Araujo Queiroz; Adriano Gonçalves E Silva; Fabio de Oliveira Ferreira; Rodrigo Ramella Munhoz
Journal:  Case Rep Oncol       Date:  2022-03-04

6.  New familial cases of karyomegalic interstitial nephritis with mutations in the FAN1 gene.

Authors:  Imen Rejeb; Mouna Jerbi; Houweyda Jilani; Hanène Gaied; Yasmina Elaribi; Syrine Hizem; Raja Aoudia; Hafedh Hedri; Chiraz Zaied; Salwa Abid; Hassen Bacha; Taieb BenAbdallah; Lamia BenJemaa; Rim Goucha
Journal:  BMC Med Genomics       Date:  2021-06-14       Impact factor: 3.063

7.  Karyomegalic interstitial nephritis with a novel FAN1 gene mutation and concurrent ALECT2 amyloidosis.

Authors:  Steven Law; Julian Gillmore; Janet A Gilbertson; Paul Bass; Alan D Salama
Journal:  BMC Nephrol       Date:  2020-02-28       Impact factor: 2.388

8.  Pulmonary manifestations of systemic karyomegaly.

Authors:  Levent M Akyürek; Aziz Hussein; Andrew G Nicholson; Nils-Johan Mauritz; Johan Mölne
Journal:  Respir Med Case Rep       Date:  2020-02-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.